Clinical Trial

Neural Cardiac Therapy for Heart Failure Study (NECTAR-HF)

Study acronym: NECTAR-HF
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The NECTAR-HF feasibility trial is designed to evaluate the application of right vagal nerve stimulation in heart failure patients with a New York Heart Association Class III, an ejection fraction equal to or less than 35 %, and a narrow QRS duration equal to or less than 130 ms.
Protocol Amendment History 1 change
minor Completion pushed: 2026-06-30 -> 2027-06-30 2026-08-15
Trial Details
NCT Number NCT01385176
Lead Sponsor Boston Scientific Corporation
Conditions Heart Failure, Congestive Heart Failure
Enrollment 118 participants
Start Date 2011-09-21
Primary Completion 2014-05 (estimated)
Study Completion 2027-06-30 (estimated)
Updated on ClinicalTrials.gov 2026-08-14